Our Science – Barr Website
Frederic G. Barr, M.D., Ph.D.
Selected Publications |
 |
| 1)
Olanich ME, Barr FG. A call to ARMS: targeting the PAX3-FOXO1 gene in alveolar rhabdomyosarcoma. Expert Opin. Ther. Targets. [Epub ahead of print], 2013. [Journal] |
|
| 2)
Skapek SX, Anderson J, Barr FG, Bridge JA, Gastier-Foster JM, Parham DM, Rudzinski ER, Triche T, Hawkins DS. PAX-FOXO1 Fusion Status Drives Unfavorable Outcome for Children With Rhabdomyosarcoma: A Children's Oncology Group Report. Pediatr Blood Cancer. [Epub ahead of print], 2013. [Journal] |
|
| 3)
Duan F, Smith LM, Gustafson DM, Zhang C, Dunlevy MJ, Gastier-Foster JM, Barr FG. Genomic and clinical analysis of fusion gene amplification in rhabdomyosarcoma: A report from the Children's Oncology Group. Genes Chromosomes Cancer. 51: 662-74, 2012. [Journal] |
|
| 4)
Barr FG. New Treatments for Rhabdomyosarcoma: the Importance of Target Practice. Clin. Cancer Res. 18: 595-597, 2012. [Journal] |
|
| 5)
Shukla N, Ameur N, Yilmaz I, Nafa K, Lau CY, Marchetti A, Borsu L, Barr FG, Ladanyi M. Oncogene mutation profiling of pediatric solid tumors reveals significant subsets of embryonal rhabdomyosarcoma and neuroblastoma with mutated genes in growth signaling pathways. Clin. Cancer Res. 18: 748-57, 2012. [Journal] |
|
| 6)
Tarnowski M, Schneider G, Amann G, Clark G, Houghton P, Barr FG, Kenner L, Ratajczak MZ, Kucia M. RasGRF1 regulates proliferation and metastatic behavior of human alveolar rhabdomyosarcomas. Int J Oncol. 41:: 995-1004, 2012. [Journal] |
|
| 7)
Haspel RL, Atkinson JB, Barr FG, Kaul KL, Leonard DG, O"Daniel J, Rinder HM, Scott J, Sobel ME, Speights V. TRIG on TRACK: Educating Pathology Residents in Genomic Medicine. Personalized Medicine. 9: 187-293, 2012. [Journal] |
|
| 8)
Rubin BP, Nishijo K, Chen HI, Yi X, Schuetze DP, Pal R, Prajapati SI, Abraham J, Arenkiel BR, Chen QR, Davis S, McCleish AT, Capecchi MR, Michalek JE, Zarzabal LA, Khan J, Yu Z, Parham DM, Barr FG, Meltzer PS, Chen Y, Keller C. Evidence for an unanticipated relationship between undifferentiated pleomorphic sarcoma and embryonal rhabdomyosarcoma. Cancer Cell. 19: 177-91, 2011. [Journal] |
|
| 9)
Reichek JL, Duan F, Smith LM, Gustafson DM, O'Connor RS, Zhang C, Dunlevy MJ, Gastier-Foster JM, Barr FG. Genomic and clinical analysis of amplification of the 13q31 chromosomal region in alveolar rhabdomyosarcoma: a report from the Children's Oncology Group. Clin. Cancer Res. 17: 1463-73, 2011. [Journal] |
|
| 10)
Pressey JG, Anderson JR, Crossman DK, Lynch JC, Barr FG. Hedgehog pathway activity in pediatric embryonal rhabdomyosarcoma and undifferentiated sarcoma: a report from the Children's Oncology Group. Pediatr Blood Cancer. 57: 930-8, 2011. [Journal] |
|
| Click Here to View Collapsed Bibliography. |
This page was last updated on 4/5/2013.
